6-year-old girl dies after parents paid $860K for experimental therapy that ‘shouldn’t have gone to trial’

A tragic case in China has left a family mourning the loss of their six-year-old daughter, who died following an unproven experimental gene therapy. The parents paid researchers $860,000 for the treatment, which aimed to address the child's genetic developmental disorder. Experts are now questioning the ethics and oversight of the medical team involved.

Reports indicate that the treatment, a form of base editing, had not undergone human trials prior to this case. Despite warning signs in animal studies, including liver and kidney damage in monkeys that received the therapy, the procedure moved forward. The child developed a high fever and organ failure shortly after the infusion and passed away in the ICU the following day.

Critics highlight a pattern of dangerous shortcuts taken in the name of scientific prestige. Researchers involved allegedly downplayed risks and failed to disclose the potential for a fatal immune response. The doctor leading the project, Zilong Qiu, later published research on the technique without referencing the patient's death, further fueling concerns about scientific transparency.

The medical school affiliated with the research team has launched a formal investigation into the matter. This case underscores the dangers of applying high-risk, experimental biotechnology to patients when safety protocols are ignored or bypassed by those seeking academic advancement.